666 related articles for article (PubMed ID: 23415602)
1. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
[TBL] [Abstract][Full Text] [Related]
2. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study.
Chatterjee Adhikari M; Guin A; Chakraborty S; Sinhamahapatra P; Ghosh A
Semin Arthritis Rheum; 2012 Apr; 41(5):669-75. PubMed ID: 22035626
[TBL] [Abstract][Full Text] [Related]
3. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.
Syngle A; Vohra K; Kaur L; Sharma S
Scand J Rheumatol; 2009; 38(1):15-22. PubMed ID: 18766955
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
Syngle A; Vohra K; Garg N; Kaur L; Chand P
Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
[TBL] [Abstract][Full Text] [Related]
5. Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients.
Sidiropoulos PI; Siakka P; Pagonidis K; Raptopoulou A; Kritikos H; Tsetis D; Boumpas DT
Scand J Rheumatol; 2009; 38(1):6-10. PubMed ID: 18991190
[TBL] [Abstract][Full Text] [Related]
6. Impaired brachial artery flow-mediated dilation and increased carotid intima-media thickness in rheumatoid arthritis patients.
Fan CY; Zhang ZY; Mei YF; Wu CJ; Shen BZ
Chin Med J (Engl); 2012 Mar; 125(5):832-7. PubMed ID: 22490583
[TBL] [Abstract][Full Text] [Related]
7. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
[TBL] [Abstract][Full Text] [Related]
8. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial.
Tam LS; Shang Q; Li EK; Wang S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
J Rheumatol; 2012 Dec; 39(12):2267-75. PubMed ID: 22984272
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.
Turiel M; Tomasoni L; Sitia S; Cicala S; Gianturco L; Ricci C; Atzeni F; De Gennaro Colonna V; Longhi M; Sarzi-Puttini P
Cardiovasc Ther; 2010 Oct; 28(5):e53-64. PubMed ID: 20337633
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of brachial flow-mediated dilation in patients with rheumatoid arthritis.
Watanabe T; Takemura M; Sato M; Matsunami H; Seishima M; Shimizu K; Matsuoka T
Int J Rheum Dis; 2014 Jan; 17(1):26-33. PubMed ID: 24472263
[TBL] [Abstract][Full Text] [Related]
12. The role of microalbuminuria as a predictor of subclinical cardiovascular events in rheumatoid arthritis patients and its relation to disease activity.
Nada DW; El Morsy S; Abu-Zaid MH; Aboelhawa MA; Zakaria MA; El Sheikh EA; Gaber RA
Clin Rheumatol; 2018 Mar; 37(3):623-630. PubMed ID: 29063462
[TBL] [Abstract][Full Text] [Related]
13. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.
Végh E; Kerekes G; Pusztai A; Hamar A; Szamosi S; Váncsa A; Bodoki L; Pogácsás L; Balázs F; Hodosi K; Domján A; Szántó S; Nagy Z; Szekanecz Z; Szűcs G
Rheumatol Int; 2020 Mar; 40(3):427-436. PubMed ID: 31848735
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.
Tam LS; Shang Q; Li EK; Wong S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
Semin Arthritis Rheum; 2013 Feb; 42(4):333-45. PubMed ID: 22920235
[TBL] [Abstract][Full Text] [Related]
16. Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis--a single centre study using non-biologic drugs.
Chatterjee S; Sarkate P; Ghosh S; Biswas M; Ghosh A
J Assoc Physicians India; 2013 Aug; 61(8):531-4. PubMed ID: 24818335
[TBL] [Abstract][Full Text] [Related]
17. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
[TBL] [Abstract][Full Text] [Related]
18. Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up.
Tiippana-Kinnunen T; Paimela L; Kautiainen H; Laasonen L; Leirisalo-Repo M
Scand J Rheumatol; 2010; 39(1):12-8. PubMed ID: 20132065
[TBL] [Abstract][Full Text] [Related]
19. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.
Galarraga B; Belch JJ; Pullar T; Ogston S; Khan F
J Rheumatol; 2010 Mar; 37(3):521-8. PubMed ID: 20080919
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Treatments for Rheumatoid Arthritis on Endothelial Dysfunction Evaluated by Flow-Mediated Vasodilation in Patients with Rheumatoid Arthritis.
Kotani K; Miyamoto M; Ando H
Curr Vasc Pharmacol; 2017; 15(1):10-18. PubMed ID: 27739363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]